Abivax SA (ABVX)
121.48
-4.32
(-3.43%)
USD |
NASDAQ |
Apr 15, 16:00
121.00
-0.48
(-0.40%)
After-Hours: 20:00
Abivax Research and Development Expense (Annual) : 200.62M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 13.84B |
| Eli Lilly & Co. | 13.34B |
| DBV Technologies SA | 107.12M |
| Insmed, Inc. | 771.09M |
| Nicox SA | 6.446M |